Learning Objectives (Draft)

CAGPO 2017 Conference General Learning Objective

At the completion of this conference, the attendee will have acquired knowledge regarding:
  • The standard of care in the treatment of metastatic non-small cell lung cancer pertaining to oral targeted therapies and immune-oncology drugs;
  • An update on the management of renal cancer, includind surgery, radiation and chemotherapy;
  • Management of the toxicities associated with immune-targeted therapies used in the treatment of bladder cancer;
  • Evidence-based follow-up protocols for patients who have received adjuvant therapy for lymphoma and ovarian cancer;
  • Bone marrow transplantation and how to manage the most common complications and toxicities;
  • Recent advances in the role of anti-estrogen therapy in breast cancer;
  • Practice changing data from ASCO 2017;
  • Management of HPV related oral cancer;
  • The treatment of right and left colon cancers - are they different?
  • Providing follow-up care to breast cancer patients - what needs to be done beyond a mammogram;
  • An approach to assessing the geriatric oncology patient;
  • The role of rehabilitation for the oncology patient;
  • Management of lymphedema;
  • Treatment of neuropathic pain and cancer cachexia;
  • Challenging thrombosis scenarios including the potential role of NOACs in oncology patients receiving treatment;
  • What dietary advice a GPO should give patients regarding diet and cancer;
  • Recent changes in the treatment of hypertension, diabetes and lipid abnormalities as tthey pertain to oncology treatments;
  • Recognizing burnout in yourself and your colleagues.

CAGPO 2017 Talk Specific Learning Objectives


1. Hormone receptor positive breast cancer
At the conclusion of this activity, participants will be able to compare the benefits of 5 versus 10 years of adjuvant hormonal therapy with either tamoxifen or the aromatase inhibitors. The participant will also be able to determine the benefit of adjuvant bisphosphonates for their patients, as well as evaluate the benefit of ovarian suppression when given with tamoxifen.

2. Metastatic Hormone Positive Breast Cancer
At the conclusion of this activity, participants will be able to comprehend the role of aromatase inhibitors and targeted therapies in the treatment of metastatic breast cancer.  The participant will be able to list the major toxicities of this combination therapy, determine when and how to sequence hormonal therapies, and comprehend how to monitor for toxicities.

3. Metastatic Non-small cell Lung Cancer
At the conclusion of this activity, participants will be able to identify systemic options for first, second and third line treatment of metastatic non-small cell lung cancer.  Participants will be able to better comprehend the efficacy and toxicities of targeted therapies.  They will be able to recognize the role for pathological testing in directing treatment.  Participants will be able to define the role of immunotherapies for non-small cell lung cancer.

4. Breast Cancer Follow-up issues beyond mammograms
At the completion of this learning activity, participants will be able to evaluate the current evident regarding follow-up care of breast cancer survivors as it pertains to surveillance and screening for recurrence.  The participants will be able to propose appropriate management of physical and psychosocial effects of cancer and it’s treatments.  They will be able to apply health promotion recommendations, and plan survivorship care amongst health care providers.

5. ASCO Update 2017
At the completion of this activity, participants be able to apply practice changing recommendations from ASCO 2017.

6. Follow-up Care Guidelines
At the completion of this activity, participants will be able to plan appropriate follow-up care for patients who have been treated for lymphoma with curative intent.
At the completion of this activity, participants will be able to plan appropriate follow-up care for patients who have been treated with adjuvant chemotherapy for ovarian cancer.

7. Scholarship Presentation
At the completion of this activity, participants will be able to evaluate the benefit to the community of the scholarship awardees funded educational activity.

8. Lymphedema (arm, leg, chest wall)
At the completion of this learning activity, participants will learn how to identify lymphedema and assess its severity.  The pathophysiology of lymphedema will be reviewed.  The participants will be able to propose appropriate exercise programs, as well as comprehend when to recommend compression garments.  Participants will be able to identify

9. Geriatric Oncology
At the completion of this learning activity, participants will be able to identify the role of the geriatrician in oncology care.  They will be able to explain how a geriatric assessment affects treatment decision-making.  They will be able to determine which patients will benefit from a geriatric assessment, and what to do when there isn’t a geriatric oncology clinic to refer patients to.

10. Bone Marrow Transplantation
At the completion of this activity, participants will be able to identify which patients are candidates for a bone marrow transplant.  They will learn how to evaluate and prepare patients for a bone marrow transplant.  They will be able to recognize the complications, and identify the short and long term risks of bone marrow transplant.

11. Renal Cancer
At the completion of this learning activity, participants will be able to identify and apply the treatment options available for renal cancer, including the role of neo-adjuvant, adjuvant and palliative systemic therapy, as well as the role for surgery.  They will be able to comprehend the role of immunotherapy and radiation therapy.  They will be able explain to role of concurrent therapy as well as palliative radiotherapy.

12. Radiation Oncology
At the completion of this activity, participants will be able to identify how to manage the burn caused by radiation, related to the treatment of head and neck cancer (mucositis), lung cancer (esophagitis and gastritis), and rectal cancer (proctitis and enteritis).  As well, participants will better comprehend the presentation of radiation necrosis from SBRT, and the role of bevacicumab if and when steroids are not effective.

13. Update on treatment of Hypercholesterolemia, Diabetes and Hypertension
At the completion of this learning activity, participants will comprehend how the management of hypercholesterolemia, diabetes and hypertension is affected by oncology medications.  Participants will be able to identify when dietary intervention isn’t adequate, and will be able to instruct their patients on appropriate medical management.

14. Physician Burnout
At the completion of this activity, participants will be able to comprehend the causes of physician burnout.  They will be able to identify the warning signs, and instruct colleagues on self-care techniques.  They will be able to indicate what any organization can do to help keep its doctors healthy.

15. Cancer Rehabilitation  
At the completion of this activity, participants will be able to identify the role of exercise and nutrition in the continuum of care for oncology patients.  They will be able to define the role of the oncology rehabilitation team.  They will be able to summarize the assessment and management of malnutrition in the care of the elderly oncology patient.  They will be able to recognize the role, if any, of medical cannabis in cancer care.  

16. HPV cancer
At the completion of this learning activity, participants will be able to identify the role of the team in the treatment of HPV head and neck cancers.  They will be able to state the role of radiation, chemotherapy and surgery in the treatment of the patient.  They will be able to comprehend an approach to toxicity management in HPV head and neck cancers.

17. Colorectal Cancer
At the completion of this activity, participants will be able to identify the present standard of care for colon cancer, including adjuvant and metastatic disease (focusing on metastatic disease).  They will be able to interpret the data regarding the different treatment recommendations for right and left sided colon cancers.  They will be able to comprehend the differences in mutations found in left versus right-sided colon cancers.

18. Cancer Pain Management 
At the completion of this learning activity, participants will be able to comprehend the prevalence of pain amongst cancer patients.  They will be able to identify the barriers to providing adequate cancer pain management.  They will be able to indicate the clinical scenarios where cancer pain becomes difficult to treat, including neuropathic pain.  They will be able to summarize the interdisciplinary approach offered at the MUHC Cancer Pain Clinic.

19. Cancer and Nutrition
At the completion of this learning activity, participants will be able to more confidently evaluate the literature pertaining to nutrition and cancer outcomes.  They will be able to more confidently advise their patients on which nutritional maneuvers are beneficial, and which are not.  They will have a better understanding of the role of nutrition in the treatment of patients with a cancer diagnosis.